Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of β-catenin

FASEB Journal

Volumn 26, Issue 11, 2012, Pages 4685-4695

  Rines, Amy K ^a   Burke, Michael A ^a   Fernandez, Richard P ^a   Volpert, Olga V ^a   Ardehali, Hossein ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

CacyBP; SNRK

Indexed keywords

BETA CATENIN; BINDING PROTEIN; CALCYCLIN BINDING PROTEIN; MESSENGER RNA; PHOSPHOTRANSFERASE; SNF1 RELATED KINASE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; COLON CANCER; DOWN REGULATION; ENZYME INHIBITION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; UPREGULATION;

BETA CATENIN; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84868286357     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-212282     Document Type: Article

References (29)

1. Celenza, J. L., and Carlson, M. (1984) Cloning and genetic mapping of SNF1, a gene required for expression of glucoserepressible genes in Saccharomyces cerevisiae. Mol. Cell. Biol. 4, 49-53
2. Hardie, D. G. (2007) AMP-Activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat. Rev. Mol. Cell. Biol. 8, 774-785
3. Fogarty, S., and Hardie, D. G. (2010) Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim. Biophys. Acta 1804, 581-591
4. Wong, A. K., Howie, J., Petrie, J. R., and Lang, C. C. (2009) AMP-Activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease. Clin. Sci. (Lond.) 116, 607-620
5. Bright, N. J., Thornton, C., and Carling, D. (2009) The regulation and function of mammalian AMPK-related kinases. Acta Physiol. (Oxf.) 196, 15-26
6. Hurov, J., and Piwnica-Worms, H. (2007) The Par-1/MARK family of protein kinases: from polarity to metabolism. Cell Cycle 6, 1966-1969
7. Yoshida, K., Yamada, M., Nishio, C., Konishi, A., and Hatanaka, H. (2000) SNRK, a member of the SNF1 family, is related to low K-induced apoptosis of cultured rat cerebellar granule neurons. Brain Res. 873, 274-282
8. Becker, W., Heukelbach, J., Kentrup, H., and Joost, H. G. (1996) Molecular cloning and characterization of a novel mammalian protein kinase harboring a homology domain that defines a subfamily of serine/threonine kinases. Eur. J. Biochem. 235, 736-743
9. Kertesz, N., Samson, J., Debacker, C., Wu, H., and Labastie, M. C. (2002) Cloning and characterization of human and mouse SNRK sucrose non-fermenting protein (SNF-1)-related kinases. Gene 294, 13-24
10. Chun, C. Z., Kaur, S., Samant, G. V., Wang, L., Pramanik, K., Garnaas, M. K., Li, K., Field, L., Mukhopadhyay, D., and Ramchandran, R. (2009) Snrk-1 is involved in multiple steps of angioblast development and acts via notch signaling pathway in artery-vein specification in vertebrates. Blood 113, 1192-1199
11. Jaleel, M., McBride, A., Lizcano, J. M., Deak, M., Toth, R., Morrice, N. A., and Alessi, D. R. (2005) Identification of the sucrose non-fermenting related kinase SNRK, as a novel LKB1 substrate. FEBS Lett. 579, 1417-1423
12. Lizcano, J. M., Goransson, O., Toth, R., Deak, M., Morrice, N. A., Boudeau, J., Hawley, S. A., Udd, L., Makela, T. P., Hardie, D. G., and Alessi, D. R. (2004) LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 23, 833-843
13. Schneider, G., and Filipek, A. (2011) S100A6 binding protein and Siah-1 interacting protein (CacyBP/SIP): spotlight on properties and cellular function. Amino Acids 41, 773-780
14. Filipek, A., and Kunicki, J. (1998) Molecular cloning and expression of a mouse brain cDNA encoding a novel protein target of calcyclin. J. Neurochem. 70, 1793-1798
15. Matsuzawa, S. I., and Reed, J. C. (2001) Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol. Cell. 7, 915-926
16. Tetsu, O., and McCormick, F. (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426
17. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler, K. W. (1998) Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512
18. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. W. (1997) Activation of betacatenin-Tcf signaling in colon cancer by mutations in betacatenin or APC. Science 275, 1787-1790
19. Edgar, R., Domrachev, M., and Lash, A. E. (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucl. Acids Res. 30, 207-210
20. Veeman, M. T., Slusarski, D. C., Kaykas, A., Louie, S. H., and Moon, R. T. (2003) Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr. Biol. 13, 680-685
21. Ning, X., Sun, S., Hong, L., Liang, J., Liu, L., Han, S., Liu, Z., Shi, Y., Li, Y., Gong, W., Zhang, S., Chen, Y., Guo, X., Cheng, Y., Wu, K., and Fan, D. (2007) Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Mol. Cancer Res. 5, 1254-1262
22. Santelli, E., Leone, M., Li, C., Fukushima, T., Preece, N. E., Olson, A. J., Ely, K. R., Reed, J. C., Pellecchia, M., Liddington, R. C., and Matsuzawa, S. (2005) Structural analysis of Siah1-Siahinteracting protein interactions and insights into the assembly of an E3 ligase multiprotein complex. J. Biol. Chem. 280, 34278-34287
23. Major, M. B., Camp, N. D., Berndt, J. D., Yi, X., Goldenberg, S. J., Hubbert, C., Biechele, T. L., Gingras, A. C., Zheng, N., Maccoss, M. J., Angers, S., and Moon, R. T. (2007) Wilms tumor suppressor WTX negatively regulates WNT/α-catenin signaling. Science 316, 1043-1046
24. Da Costa, L. T., He, T. C., Yu, J., Sparks, A. B., Morin, P. J., Polyak, K., Laken, S., Vogelstein, B., and Kinzler, K. W. (1999) CDX2 is mutated in a colorectal cancer with normal APC/α-catenin signaling. Oncogene 18, 5010-5014
25. Sun, S., Ning, X., Liu, J., Liu, L., Chen, Y., Han, S., Zhang, Y., Liang, J., Wu, K., and Fan, D. (2007) Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma. Biochem. Biophys. Res. Commun. 356, 864-871
26. Fukushima, T., Zapata, J., Singha, N., Thomas, M., Kress, C., Krajewska, M., Krajewski, S., Ronai, Z., Reed, J., and Matsuzawa, S. (2006) Critical function for SIP, a ubiquitin E3 ligase component of the beta-catenin degradation pathway, for thymocyte development and G1 checkpoint. Immunity 24, 29-39
27. Nie, F., Yu, X. L., Wang, X. G., Tang, Y. F., Wang, L. L., and Ma, L. (2010) Down-regulation of CacyBP is associated with poor prognosis and the effects on COX-2 expression in breast cancer. Int. J. Oncol. 37, 1261-1269
28. Chen, X., Mo, P., Li, X., Zheng, P., Zhao, L., Xue, Z., Ren, G., Han, G., Wang, X., and Fan, D. (2011) CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells. Mol. Carcinog. 50, 804-810
29. Zhai, H., Shi, Y., Jin, H., Li, Y., Lu, Y., Chen, X., Wang, J., Ding, L., Wang, X., and Fan, D. (2008) Expression of calcyclin-binding protein/Siah-1 interacting protein in normal and malignant human tissues: an immunohistochemical survey. J. Histochem. Cytochem. 56, 765-772